Results
|
841.
|
|
|
842.
|
|
|
843.
|
|
|
844.
|
|
|
845.
|
|
|
846.
|
|
|
847.
|
|
|
848.
|
|
|
849.
|
|
|
850.
|
|
|
851.
|
|
|
852.
|
|
|
853.
|
|
|
854.
|
|
|
855.
|
|
|
856.
|
|
|
857.
|
Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors. [electronic resource] by
- Desai, Jayesh
- Gan, Hui
- Barrow, Catherine
- Jameson, Michael
- Atkinson, Victoria
- Haydon, Andrew
- Millward, Michael
- Begbie, Stephen
- Brown, Michael
- Markman, Ben
- Patterson, William
- Hill, Andrew
- Horvath, Lisa
- Nagrial, Adnan
- Richardson, Gary
- Jackson, Christopher
- Friedlander, Michael
- Parente, Phillip
- Tran, Ben
- Wang, Lai
- Chen, Yunxin
- Tang, Zhiyu
- Huang, Wendy
- Wu, John
- Zeng, Dewan
- Luo, Lusong
- Solomon, Benjamin
Producer: 20210202
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 38
Availability: No items available.
|
|
858.
|
|
|
859.
|
|
|
860.
|
|